Clinical Trial Update: Efficacy of Dexamethasone for Prevent Vomiting in Leukemic Children Who Receive Intrathecal Chemotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether dexamethasone reduces vomiting in children with acute leukemia receiving intrathecal chemotherapy; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: CHANCHAI TRAIVAREE | Conditions: Acute Leukemic Patients in Children | Phase 4 | Status: COMPLETED